Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) - Total Liabilities

Latest as of December 2025: ₫862.89 Billion VND ≈ $32.78 Million USD

Based on the latest financial reports, Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has total liabilities worth ₫862.89 Billion VND (≈ $32.78 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Binh Dinh Pharmaceutical and Medical Equ cash flow conversion to assess how effectively this company generates cash.

Binh Dinh Pharmaceutical and Medical Equipment JSC - Total Liabilities Trend (2020–2025)

This chart illustrates how Binh Dinh Pharmaceutical and Medical Equipment JSC's total liabilities have evolved over time, based on quarterly financial data. Check DBD asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Binh Dinh Pharmaceutical and Medical Equipment JSC Competitors by Total Liabilities

The table below lists competitors of Binh Dinh Pharmaceutical and Medical Equipment JSC ranked by their total liabilities.

Company Country Total Liabilities
Eaton Vance New York MBF
NYSE MKT:ENX
USA $86.56 Million
RADCOM Ltd
F:RAM
Germany €30.21 Million
Coveo Solutions Inc
TO:CVO
Canada CA$118.67 Million
Radcom Ltd
NASDAQ:RDCM
USA $30.87 Million
Marblegate Acquisition Corp
NASDAQ:GATE
USA $24.23 Million
Yatra Online Limited
NSE:YATRA
India Rs4.89 Billion
Doktas Dokumculuk Ticaret ve Sanayi AS
IS:DOKTA
Turkey TL12.14 Billion

Liability Composition Analysis (2020–2025)

This chart breaks down Binh Dinh Pharmaceutical and Medical Equipment JSC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Binh Dinh Pharmaceutical and Medical Equ (DBD) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.51 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.50 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.33 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Binh Dinh Pharmaceutical and Medical Equipment JSC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)

The table below shows the annual total liabilities of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025.

Year Total Liabilities Change
2025-12-31 ₫862.89 Billion
≈ $32.78 Million
+43.08%
2024-12-31 ₫603.07 Billion
≈ $22.91 Million
+8.45%
2023-12-31 ₫556.07 Billion
≈ $21.13 Million
+2.86%
2022-12-31 ₫540.58 Billion
≈ $20.54 Million
+29.03%
2021-12-31 ₫418.97 Billion
≈ $15.92 Million
-6.64%
2020-12-31 ₫448.78 Billion
≈ $17.05 Million
--

About Binh Dinh Pharmaceutical and Medical Equipment JSC

VN:DBD Vietnam Drug Manufacturers - Specialty & Generic
Market Cap
$179.14 Million
₫4.72 Trillion VND
Market Cap Rank
#16949 Global
#108 in Vietnam
Share Price
₫49900.00
Change (1 day)
+0.30%
52-Week Range
₫48050.00 - ₫56700.00
All Time High
₫62000.00
About

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous … Read more